Poor survival for US Pacific Islander cancer patients: evidence from the Surveillance, Epidemiology, and End Results database: 1991 to 2004 - PubMed (original) (raw)
Comparative Study
. 2007 Dec 20;25(36):5738-41.
doi: 10.1200/JCO.2007.13.8271.
Affiliations
- PMID: 18089868
- DOI: 10.1200/JCO.2007.13.8271
Comparative Study
Poor survival for US Pacific Islander cancer patients: evidence from the Surveillance, Epidemiology, and End Results database: 1991 to 2004
William B Goggins et al. J Clin Oncol. 2007.
Abstract
Purpose: Although racial and ethnic differences in cancer survival in the United States have been studied extensively, little is known about cancer survival in US Pacific Islanders (PIs), a fast-growing and economically disadvantaged minority group.
Methods: Using data from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries, we compared cause-specific and all-cause survival for female breast, prostate, lung, colorectal, stomach and liver cancer for Native Hawaiians, Samoans, other PIs (including Tongans, Guamanians, and others), African Americans, and Native Americans with non-Hispanic whites using Cox proportional hazards models. Separate models were fitted adjusting for demographic factors only and demographic and disease severity variables.
Results: Among all groups, Samoans were the most likely to present with advanced disease and had the worst cause-specific survival for all sites considered. Samoans had particularly poor results (adjusted for demographic variables only) for female breast (relative risk [RR] = 3.05; 95% CI, 2.31 to 4.02), colorectal (RR = 1.82; 95% CI, 1.37 to 2.41) and prostate (RR = 4.82; 95% CI, 3.38 to 6.88) cancers. Native Hawaiians and other PIs also had significantly worse cause-specific survival than did non-Hispanic whites for most sites, but generally had better survival than African Americans or Native Americans.
Conclusion: Much of the survival disadvantage for PI groups appears to be a result of late diagnosis, and thus targeted interventions have much potential to reduce cancer mortality in this group. More research is needed to find explanations for the particularly poor cancer survival for Samoans in the United States.
Similar articles
- Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP. Iezzoni LI, et al. Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review. - Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008.
Goggins WB, Lo FF. Goggins WB, et al. Cancer Causes Control. 2012 May;23(5):737-43. doi: 10.1007/s10552-012-9943-8. Epub 2012 Mar 27. Cancer Causes Control. 2012. PMID: 22450738 - Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J. El-Serag HB, et al. Arch Intern Med. 2007 Oct 8;167(18):1983-9. doi: 10.1001/archinte.167.18.1983. Arch Intern Med. 2007. PMID: 17923599
Cited by
- Using community-based research methods to design cancer patient navigation training.
Braun KL, Allison A, Tsark JU. Braun KL, et al. Prog Community Health Partnersh. 2008 Winter;2(4):329-40. doi: 10.1353/cpr.0.0037. Prog Community Health Partnersh. 2008. PMID: 20208313 Free PMC article. - High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.
Zhang Y, Zhang J, Shen Q, Yin W, Huang H, Liu Y, Ni Q. Zhang Y, et al. Oncol Lett. 2018 Jun;15(6):8789-8795. doi: 10.3892/ol.2018.8365. Epub 2018 Mar 28. Oncol Lett. 2018. PMID: 29805618 Free PMC article. - Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.
White A, Coker AL, Du XL, Eggleston KS, Williams M. White A, et al. Cancer. 2011 Mar 1;117(5):1080-8. doi: 10.1002/cncr.25671. Epub 2010 Nov 8. Cancer. 2011. PMID: 21351084 Free PMC article. - Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W, Ren Y, Wang H, Wan Y, Wang D, Yao J, Pan H. Qi W, et al. Sci Rep. 2023 Dec 27;13(1):23018. doi: 10.1038/s41598-023-50401-z. Sci Rep. 2023. PMID: 38155261 Free PMC article. - Ethnic differences in breast cancer survival: status and determinants.
Maskarinec G, Sen C, Koga K, Conroy SM. Maskarinec G, et al. Womens Health (Lond). 2011 Nov;7(6):677-87. doi: 10.2217/whe.11.67. Womens Health (Lond). 2011. PMID: 22040209 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous